# Andhra Pradesh, AstraZeneca sign deal for genomic cancer centre 2026-08-07T21:53:33+00:00 | Health & Science | Indian Opinion Desk Corroboration: 1 independent outlet On Tuesday, the Andhra Pradesh government signed an MoU with AstraZeneca India to establish an Integrated Genomic Solutions Centre in Amaravati, focusing on precision oncology. The centre will offer genomic testing and biomarker analysis for lung and breast cancers, using next-generation sequencing, AI, and genomic technologies for early detection and personalised treatment. As part of the pact, AI-enabled X-ray systems will be installed in government hospitals to boost lung cancer screening. Chief Minister N. Chandrababu Naidu said the initiative, under the Amaravati Quantum Valley programme, would make advanced healthcare accessible and turn the city into a research hub. Reliance-backed Strand Life Sciences and Qure.ai are also partners. ## Coverage - thehindu.com Tags: Amaravati, Andhra Pradesh, AstraZeneca, cancer care, genomic centre, precision oncology Canonical: https://indianopinion.org/andhra-pradesh-astrazeneca-sign-deal-for-genomic-cancer-centre/ License: Summary and commentary (c) Indian Opinion, reusable with attribution. Facts belong to the linked sources. Cite: https://indianopinion.org/andhra-pradesh-astrazeneca-sign-deal-for-genomic-cancer-centre/#story-in-brief Review state: restored archive article, accurate at time of publication, not offered to search indexes.